tiprankstipranks
Trending News
More News >
Altamira Therapeutics (CYTOF)
OTHER OTC:CYTOF
US Market

Altamira Therapeutics (CYTOF) Cash flow

Compare
597 Followers

Altamira Therapeutics Cash Flow

CYTOF's free cash flow for Q2 2023 was CHF-3.86M. For the 2023 fiscal year, CYTOF's free cash flow was decreased by CHF-685.03K and operating cash flow was CHF-3.86M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
CHF -11.51MCHF -8.68MCHF -13.67MCHF -4.84MCHF -8.39M
Investing Cash Flow
CHF 1.44MCHF -2.14MCHF -3.51MCHF -2.31MCHF -3.00M
Financing Cash Flow
CHF 10.62MCHF 9.83MCHF 6.61MCHF 16.96MCHF 7.38M
End Cash Position
CHF 617.41KCHF 15.39KCHF 984.19KCHF 11.26MCHF 1.38M
Free Cash Flow
CHF -11.51MCHF -10.83MCHF -17.00MCHF -7.16MCHF -11.41M
Currency in CHF

Altamira Therapeutics Cash Flow